ATE131383T1 - Arzneimittel - Google Patents

Arzneimittel

Info

Publication number
ATE131383T1
ATE131383T1 AT91908384T AT91908384T ATE131383T1 AT E131383 T1 ATE131383 T1 AT E131383T1 AT 91908384 T AT91908384 T AT 91908384T AT 91908384 T AT91908384 T AT 91908384T AT E131383 T1 ATE131383 T1 AT E131383T1
Authority
AT
Austria
Prior art keywords
drug
medicaments
wafer
delivery
sub
Prior art date
Application number
AT91908384T
Other languages
English (en)
Inventor
Geoffrey David Tovey
City
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of ATE131383T1 publication Critical patent/ATE131383T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT91908384T 1990-04-26 1991-04-24 Arzneimittel ATE131383T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909009390A GB9009390D0 (en) 1990-04-26 1990-04-26 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE131383T1 true ATE131383T1 (de) 1995-12-15

Family

ID=10675032

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91908384T ATE131383T1 (de) 1990-04-26 1991-04-24 Arzneimittel

Country Status (15)

Country Link
EP (1) EP0526524B1 (de)
JP (1) JPH05506655A (de)
AT (1) ATE131383T1 (de)
AU (1) AU649041B2 (de)
CA (1) CA2081109A1 (de)
DE (1) DE69115476T2 (de)
DK (1) DK0526524T3 (de)
ES (1) ES2080314T3 (de)
GB (1) GB9009390D0 (de)
GR (1) GR3019298T3 (de)
IE (1) IE911381A1 (de)
NZ (1) NZ237930A (de)
PT (1) PT97476B (de)
WO (1) WO1991016041A1 (de)
ZA (1) ZA913072B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005416A2 (en) * 1993-08-19 1995-02-23 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
ATE252373T1 (de) * 1994-08-04 2003-11-15 Elan Drug Delivery Ltd Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
DK0824344T3 (da) 1995-05-09 2005-08-15 Phoqus Pharmaceuticals Ltd Pulverformig sammensætning til elektrostatisk coating af farmaceutiske substrater
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
US6238693B1 (en) 1998-04-27 2001-05-29 Elan Pharmaceuticals, Inc. Transdermal administration of fenoldopam
PT1100476E (pt) * 1998-07-24 2004-10-29 Alza Corp Formulacoes para uma administracao transdermica de fenoldopam
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
AU3884900A (en) * 1999-03-18 2000-10-04 Quing Non Yng-Wong Wafer delivery system
US6583160B2 (en) * 1999-04-14 2003-06-24 Steve Smith Nicotine therapy method and oral carrier for assuaging tobacco-addiction
ATE285220T1 (de) 1999-07-02 2005-01-15 Procter & Gamble Zusammenstzungen enthaltend organosiloxan-harze zur freisetzung von mundpflegewirkstoffen und zur verlängerung der freisetzung
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
DE102008014533A1 (de) * 2008-03-15 2009-09-17 Lts Lohmann Therapie-Systeme Ag Gingival-Wafer
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
WO2010057262A1 (en) 2008-11-21 2010-05-27 Percutaneous Cardiovascular Solutions Pty Limited Heart valve prosthesis and method
EP4119098A1 (de) 2009-04-15 2023-01-18 Edwards Lifesciences CardiAQ LLC Gefässimplantat und freisetzungssystem
CA2760461C (en) 2009-04-29 2014-10-07 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
WO2012040655A2 (en) 2010-09-23 2012-03-29 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US12502276B2 (en) 2011-05-16 2025-12-23 Edwards Lifesciences Corporation Inversion delivery device and method for a prosthesis
CN104736133B (zh) 2012-10-17 2020-07-10 宝洁公司 用于递送口腔护理活性物质的条带以及施用口腔护理活性物质的方法
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US20140277427A1 (en) 2013-03-14 2014-09-18 Cardiaq Valve Technologies, Inc. Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9532870B2 (en) 2014-06-06 2017-01-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
BR112017006248A2 (pt) 2014-09-28 2017-12-12 Cardiokinetix Inc aparelhos para o tratamento de insuficiência cardíaca
US10531951B2 (en) 2014-11-26 2020-01-14 Edwards Lifesciences Corporation Transcatheter prosthetic heart valve and delivery system
WO2016153918A1 (en) 2015-03-20 2016-09-29 Cardiokinetix, Inc. Systems and methods for delivering an implantable device
US10441416B2 (en) 2015-04-21 2019-10-15 Edwards Lifesciences Corporation Percutaneous mitral valve replacement device
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
US10639143B2 (en) 2016-08-26 2020-05-05 Edwards Lifesciences Corporation Multi-portion replacement heart valve prosthesis
EP3648708A4 (de) 2017-07-06 2021-03-31 Edwards Lifesciences Corporation Steuerbares abgabesystem und komponenten
EP3720390B1 (de) 2018-01-25 2024-05-01 Edwards Lifesciences Corporation Einführsystem zur unterstützten rückgewinnung oder neupositionierung eines klappenersatzes nach dem einsetzen
EP3952790A1 (de) 2019-04-12 2022-02-16 W.L. Gore & Associates, Inc. Ventil mit mehrteiligem rahmen und zugehörigen elastischen überbrückungsmerkmalen
ES2982566T3 (es) 2019-04-23 2024-10-16 Edwards Lifesciences Corp Sistema de suministro de implantes motorizado
JP2021147362A (ja) * 2020-03-23 2021-09-27 学校法人常翔学園 舌下投与用ゼリー剤
WO2022132569A1 (en) 2020-12-18 2022-06-23 Edwards Lifesciences Corporation Storage jar assembly for aprosthetic heart valve
KR102918984B1 (ko) 2021-10-27 2026-01-28 에드워즈 라이프사이언시스 코포레이션 인공 심장 판막의 클림핑 및 로딩을 위한 시스템 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE871821C (de) * 1950-10-24 1953-03-26 Curt Angelmi Traeger fuer Arzneimittel oder aehnliche dem Koerper einzuverleibende Stoffe
GB2022999A (en) * 1978-06-17 1979-12-28 Culpitt & Son Ltd G Paper compositions incorporating medicaments
GB2085299A (en) * 1980-10-09 1982-04-28 English Grains Ltd Treating sores using wafer-like carrier with active ingredients
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS6185315A (ja) * 1984-10-04 1986-04-30 Teikoku Seiyaku Kk シ−ト状製剤

Also Published As

Publication number Publication date
CA2081109A1 (en) 1991-10-27
EP0526524B1 (de) 1995-12-13
GB9009390D0 (en) 1990-06-20
DE69115476D1 (de) 1996-01-25
PT97476A (pt) 1992-01-31
EP0526524A1 (de) 1993-02-10
AU7748191A (en) 1991-11-11
ES2080314T3 (es) 1996-02-01
JPH05506655A (ja) 1993-09-30
DK0526524T3 (da) 1996-01-29
NZ237930A (en) 1993-08-26
IE911381A1 (en) 1991-11-06
DE69115476T2 (de) 1996-06-05
ZA913072B (en) 1992-11-25
GR3019298T3 (en) 1996-06-30
PT97476B (pt) 1998-08-31
AU649041B2 (en) 1994-05-12
WO1991016041A1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
ATE131383T1 (de) Arzneimittel
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
MX9101175A (es) Composicion farmaceutica para administracion nasal
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
SE8300736D0 (sv) Novel pharmacologically active compounds
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
DE69831971D1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
ATE427103T1 (de) Orale verabreichung von adenosin analogen
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
FI955310L (fi) Farmaseuttinen koostumus flavonoidien antamiseksi oraalisesti
LV10268A (lv) Terapeitiski aktivs benzimidazols un ta iegusanas panemiens
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
FI970331L (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
FI910088A7 (fi) Oraalinen farmaseuttinen koostumus
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
IT1238072B (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
SE9003902D0 (sv) Solid dosage forms of a drug
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
IT8219012A0 (it) Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
ITMI913306A1 (it) Composizioni farmaceutiche per la somministrazione nasale di polipeptidi.
IT8921908A0 (it) Forma di somministrazione orale del fosfato di creatina e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee